In the 20th century, public health strategies for the control of infectious disease progressed along a reductionist trajectory that emphasized vaccines, antibiotics, pesticides, and barriers to infection.
In infectious diseases practice, progress was made in the development of effective PO treatments for serious infections, although there is still substantial growth potential [ 26].
On the other hand, the widespread use of antipyretic methods in ICU patients is not supported by clinical data and fever control may be harmful, particularly when an infectious disease is progressing.
Goals on child mortality, water and infectious diseases have made significant progress, while those on maternal mortality, sanitation and essential medicines have seen limited and sometimes negligible gains [ 16, 29- 32].
First came improvements in sanitation and sewage, then remarkable progress against infectious diseases.
But as nations across the continent have made remarkable progress against infectious diseases once thought too daunting to tackle, more people are living long enough to develop cancer, and the disease is coming to the forefront.
But women in most countries now live longer than they did 40 years ago, thanks to progress against infectious diseases like flu, tuberculosis and pneumonia.
The range and burden of infectious diseases have decreased the socioeconomic progress of India.
While the gradual implementation and enforcement of the Blood Donation Law in China has generally promoted screening and diagnosis of potential infectious diseases among plasma donors, the progress has been uneven.
Though research in the field of genetic susceptibility to infectious diseases started in 1954, recent progress in genomics led to the characterization of molecular biomarkers and pathways as targets for diagnosis or intervention [ 3].
